These are conditions where the body's immune system mistakenly attacks the nervous system, causing inflammation. This inflammation can damage nerve cells and affect how the brain and spinal cord work. Think of it like the body's defense system getting confused and attacking its own tissues.
Every report comes from a Lived member, sent anonymously.
Have you tried Solu-Medrol (Methylprednisolone Hemisuccinate) for Neuroinflammatory Diseases?
Neuroinflammatory diseases are conditions in which inflammation damages the brain, the spinal cord or the optic nerves (the nerves that carry vision from the eyes to the brain). The inflammation comes from the immune system. Sometimes it is fighting an infection that has reached the nervous system; sometimes it mistakenly attacks healthy nerve tissue. Depending on where the inflammation strikes, it can cause vision loss, numbness, weakness, trouble with balance or bladder control, confusion, seizures or changes in memory and behavior. This is an umbrella term rather than a single diagnosis. It includes multiple sclerosis (MS), the most common example; neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD), which mainly affect the optic nerves and spinal cord; acute disseminated encephalomyelitis (ADEM), usually a single attack in children; encephalitis, meaning inflammation of the brain; and transverse myelitis, inflammation across a section of the spinal cord. These conditions differ in cause, course and treatment, so identifying which one a person has is the most important step. Researchers also use the word neuroinflammation more broadly, to describe immune activity in the brain that contributes to diseases such as Alzheimer's. That is an active area of research, not a separate diagnosis or an established target for treatment.
Two broad processes lead to inflammation in the nervous system. In infectious forms, a virus or, less often, bacteria, fungi or parasites reach the brain or spinal cord. Herpes simplex virus and mosquito- or tick-borne viruses such as West Nile are among the recognized causes of encephalitis in the US. In autoimmune forms, the immune system produces cells or antibodies that attack the body's own nerve tissue. In MS this attack targets myelin, the protective coating around nerve fibers. In NMOSD most people have antibodies against a protein called aquaporin-4, and in MOGAD the antibodies target a myelin protein. Sometimes the two overlap: an infection or, rarely, a vaccine can set off an immune reaction that then turns against the nervous system, as in ADEM. Some autoimmune encephalitis is triggered by a tumor elsewhere in the body, because the immune response aimed at the tumor also recognizes brain cells. Risk depends on the specific disease. MS is more common in women, and having a parent or sibling with MS raises the chance, although it is not directly inherited; past Epstein-Barr virus infection, low vitamin D and smoking are associated with higher risk. NMOSD is more common in women, Black Americans and people with other autoimmune diseases. A weakened immune system raises the risk of infectious encephalitis. In many cases, especially transverse myelitis, no specific cause is found.
Diagnosis starts with a careful history and a neurological examination, which checks vision, strength, sensation, reflexes, coordination and thinking. The pattern of symptoms, how fast they appeared and any recent infection, travel or tick and mosquito exposure all help narrow the possibilities. MRI (magnetic resonance imaging) is the central test. It shows areas of inflammation in the brain and spinal cord, and their size, shape and location help distinguish MS from NMOSD, ADEM and other causes. MRI also rules out problems that can look similar, such as a stroke, a tumor or a spinal cord pressed on by a disc or growth. A lumbar puncture (spinal tap) collects a small sample of the fluid around the brain and spinal cord. That fluid can show signs of infection or inflammation and certain proteins typical of MS. Blood and spinal fluid can also be tested for specific antibodies, such as aquaporin-4 or MOG antibodies, or antibodies linked to autoimmune encephalitis. Other tests may include an EEG (a recording of the brain's electrical activity) when seizures or confusion are present, eye tests that measure the optic nerve, and screening for a hidden tumor when autoimmune encephalitis is suspected. No single test settles every case. Antibody results can take days or weeks, so specialists often begin treatment based on the overall picture once infection has been treated or ruled out.
Treatment depends on the specific diagnosis, but it generally has two separate jobs: calming an active attack quickly, and, for conditions that tend to return, preventing future attacks. If an infection is the cause, it is treated directly where possible, for example with the antiviral acyclovir for herpes simplex encephalitis. For autoimmune attacks, high-dose corticosteroids (anti-inflammatory steroids such as methylprednisolone, usually given by vein for a few days) are the usual first step. In MS they speed recovery from an attack but do not change the long-term course. When steroids are not enough, plasma exchange, a procedure that filters harmful antibodies out of the blood, or IVIG (intravenous immunoglobulin, donated antibodies that dampen the immune response) may be used. For autoimmune encephalitis linked to a tumor, removing or treating the tumor is part of treatment. Prevention matters most in chronic, relapsing conditions. In MS, disease-modifying therapies, available as injections, pills or infusions such as ocrelizumab (Ocrevus) and natalizumab (Tysabri), reduce the number and severity of relapses and can slow long-term disability. They work best in relapsing forms of MS. In NMOSD, several medicines are approved by the US Food and Drug Administration specifically to prevent attacks in adults who have aquaporin-4 antibodies; other immune-suppressing drugs such as rituximab are also used long term, including for people without those antibodies. Choosing among these involves a real trade-off: the more strongly a medicine suppresses the immune system, the more it tends to raise the risk of infections, which is why regular blood tests and monitoring are part of treatment. Natalizumab, for example, is highly effective but carries a risk of a rare, serious brain infection; blood tests help estimate each person's risk, and MRI scans watch for early signs. Rehabilitation is an important part of care for lasting effects. Physical, occupational and speech therapy, medicines for nerve pain, stiffness and bladder problems, and support for fatigue and mood can make daily life more manageable.
The course depends heavily on which condition a person has. Some conditions are typically one-time events: most children with ADEM begin to improve within days of treatment and many recover fully within six months, and many people with transverse myelitis recover at least partly, mostly within the first three months. Others are lifelong. MS and most NMOSD follow a pattern of attacks separated by quieter periods, and some people with MS later develop a slow, steady worsening, while a smaller group have gradual worsening from the start. Most people with MS have a normal life expectancy. Recovery after an attack can be slow and incomplete. Encephalitis can leave lasting problems with memory, concentration or mood that improve over months, and some people need cognitive rehabilitation. Spinal cord inflammation can leave weakness, numbness or bladder and bowel changes, though strength and function can keep improving with rehabilitation even years later. In NMOSD, each attack can add new damage, which is why preventing attacks is the main goal. For chronic conditions, care becomes a long-term partnership with a neurologist, often at a specialized center. Expect regular check-ups, periodic MRI scans to look for silent new inflammation, and blood tests while on immune-suppressing treatment. Living with a relapsing condition also means planning work, family life and future decisions, such as pregnancy, together with the care team, because treatment choices can affect them.
Arrange a medical evaluation for neurological symptoms that develop over hours to days and last more than a day, such as blurred or lost vision in one eye with pain on moving the eye, numbness or tingling, double vision or unsteady walking. If you already have a diagnosis such as MS or NMOSD, contact your neurology team promptly about new or clearly worsening symptoms lasting more than a day, since an attack may need treatment and can signal that preventive treatment should be reviewed. Contact them too about fever or signs of infection while taking immune-suppressing medicines. Go to an emergency department for confusion, a change in personality or behavior, a seizure, unusual drowsiness or hallucinations, especially with fever or headache, because encephalitis can worsen quickly and early treatment matters. Arm or leg weakness that worsens over hours to days, or new loss of bladder or bowel control, also needs emergency assessment, both to treat spinal cord inflammation early and to rule out a spinal cord that is being compressed. Call 911 for symptoms that start suddenly, within minutes, such as one-sided weakness or numbness, sudden vision loss or trouble speaking, even if they fade, because they can signal a stroke.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Neuroinflammatory Diseases is like, what's helped you, or ask the community a question.